Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Sensex Falls 300 Points; L&T and Infosys Top Losers
Wed, 8 Jan 12:30 pm

Share markets in India are presently trading on a negative note. Benchmark indices fell nearly 1% in early trade today tracking a decline in global markets after Iran fired missiles at multiple bases housing US troops in Iraq.

Barring telecom sector, all sectoral indices are trading on a negative note with stocks in the metal sector, realty sector and automobile sector witnessing most of the selling pressure.

The BSE Sensex is trading down by 277 points (down 0.7%), while the NSE Nifty is trading down by 92 points (down 0.8%).

The BSE MidCap index is trading down by 0.6%, while the BSE SmallCap index is trading down by 0.3%.

The rupee is currently trading at 71.03 against the US$.

The domestic currency opened lower by 19 paise at 72.02 per dollar versus previous close 71.83.

In latest developments from the IPO space, Shriram Properties has reduced the size of its proposed initial public offering (IPO) to Rs 7.5 billion. The developer had planned to raise up to Rs 12.5 billion earlier.

The Bengaluru-based builder, part of the Shriram Group, had received approval from capital markets regulator to float an IPO in April 2018.

Reportedly, the company is planning to launch its IPO after the Union Budget in February.

Shriram Properties, which has projects largely in southern property markets such as Chennai and Bengaluru, has Rs 5.9 billion of debt, and will mainly use the proceeds of the share sale to pare its leverage level.

The developer plans to raise around Rs 2.5 billion through the primary market and the rest from the secondary market.

Reports state that the company has already got commitments of around Rs 4 billion from around nine investors. Shriram Properties currently has Tata Capital, TPG, Starwood Capital Group and Walton Street Capital as entity-level investors.

Note that the real estate sector has been going through a prolonged slowdown. This has impacted the residential segment the most and IPOs have largely been out of favour.

Mumbai-based Lodha Group, which got regulator's approval for an IPO in July 2018, decided not to launch the share sale till the overall market and real estate sector conditions turned conducive.

How this IPO sails through remains to be seen.

Speaking of IPOs, note that the year 2019 didn't see much activity in the IPO market. Since the start of the year, there were just 16 IPOs on the BSE main board.

Even the ones that hit the primary markets were mostly small to mid-sized IPOs. And no mega IPOs.

Very few companies come out with IPOs during bearish market conditions. So, when the IPO market is sluggish, you must take that as an indicator of market sentiment and liquidity conditions.

It is interesting to note that despite the tepid market conditions, most of the companies gave positive listing day gains.

In fact, if you had invested in each one of them and held them till now, your gains would have been even better.

The chart below shows the top five performing IPOs of 2019:

Top 5 Winning IPOs of 2019

So, unlike bull markets wherein selling shareholders do their best to squeeze the highest price, bear markets often offer fantastic opportunities to spot great companies and get onboard early on.

Moving on to news from the pharma sector, Biocon's subsidiary - Biocon Biologics India has received its board approval for primary equity investment by True North.

As per the terms of the proposed agreement, True North will invest Rs 5.4 billion in Biocon Biologics that will eventually translate to a 2.4% minority stake in the biosimilars business post all restructuring.

Post the completion of this transaction, Biocon will hold 96.07% stake in Biocon Biologics.

Biocon share price is presently trading down by 0.6%.

Speaking of the pharma sector, in the video below, Tanushree talks in great detail about the pharma sector.

She tells us where the sector stands now and also about the potential for a rebound.

Tune in to find out more...

To know what's moving the Indian stock markets today, check out the most recent share market updates here.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Sensex Falls 300 Points; L&T and Infosys Top Losers". Click here!